AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Tempus AI vs DAX Copilot

Tempus AI

Tempus AI

VS
DAX Copilot

DAX Copilot

Verdict by Category

Detailed category analysis is not available for this comparison.
View Tempus AI View DAX Copilot

Detailed Comparison

Feature
Tempus AI
DAX Copilot
Pricing
CustomTempus operates multiple revenue streams with different access models. Clinical genomic tests (xT, xG, xR, xF, xE) are ordered by physicians through the standard laboratory test ordering process. Pricing varies by test type and is typically covered by insurance for oncology patients. Tempus works directly with health systems to integrate ordering into EHR workflows. Enterprise data platform access, Algos population health analytics, and biopharma research partnerships are priced through custom enterprise licensing agreements. Biopharma companies license Tempus's de-identified patient datasets and analytical services for drug development and clinical trial design. Tempus is publicly traded on NASDAQ (ticker: TEM) since June 2024. Investor and enterprise partnership inquiries can be directed through tempus.com.
CustomMicrosoft does not publish self-serve pricing for DAX Copilot / Dragon Copilot; access is sold through Microsoft sales or authorized Cloud Solution Provider resellers, and pricing has varied significantly by channel and date. For years, authorized resellers commonly quoted $369-$830+ per provider per month plus a one-time setup fee (often around $650-$700), depending on contract size and minimum term. In a May 2026 marketplace restructuring, Microsoft published tiered list pricing including a Flex plan at roughly $604.80 per user per month (base license plus pay-as-you-go ambient use) and a higher uncapped Per-User tier around $1,512 per user per month (itself a 57% cut from a prior list price). A lower-cost "Physician Practice" license aimed at 5-50 clinician offices was briefly offered via the CSP channel at roughly $150-$160 per user per month before reaching end-of-sale on May 1, 2026. Large health systems negotiating volume, multi-year contracts frequently report effective rates well below these list prices. There is no public free trial for individual purchase, though Microsoft runs structured 30-90 day enterprise pilot programs for qualifying health systems.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
AI precision medicine platform — genomic profiling, clinical insights, and trial matching for personalized cancer care
Microsoft's enterprise ambient AI for physicians, nurses, and radiologists — formerly Nuance DAX
Tempus AI

Tempus AI Pros & Cons

Pros

  • Publicly traded (NASDAQ: TEM) — one of the most credible precision medicine AI companies
  • 7M+ de-identified patient records — one of the world's largest clinical-molecular datasets
  • Comprehensive genomic testing across 6 test types covering all major oncology applications
  • Tempus One AI provides real-time clinical insights at the point of care
  • TIME Trial dramatically improves clinical trial matching and enrollment rates
  • 3,800+ employees and $8.79B total capital raised since founding
  • Expanding beyond oncology into neuropsychiatry, cardiology, and infectious disease

Cons

  • Enterprise and institutional pricing — not accessible to individual clinicians or small practices
  • Focused primarily on oncology and genomics — not a general-purpose clinical AI tool
  • Genomic test turnaround requires laboratory processing time
  • Data platform access and licensing requires formal agreements
  • Some AI insights require institutional genomic data infrastructure to fully leverage
DAX Copilot

DAX Copilot Pros & Cons

Pros

  • Broadest role coverage of any major ambient AI platform, spanning physicians, nurses, and radiologists in one product family
  • Deepest, longest-running Epic integration in the category, built on two decades of Dragon speech technology
  • Backed by Microsoft's security, compliance (HITRUST, SOC 2 Type II), and Azure infrastructure at massive scale
  • Extensible via a Developer Kit and third-party app marketplace rather than a closed, single-vendor tool
  • Strong, publicly documented customer outcomes (time-in-note reductions, added appointments) across large health systems
  • Available across multiple countries for physicians, with continued regional expansion

Cons

  • No public pricing; buyers must go through Microsoft sales or a reseller, and quoted rates vary enormously (roughly $150 to $1,500+ per provider per month across sources)
  • No self-serve signup or public free trial, unlike most consumer-facing AI scribes; enterprise procurement is required even for small practices
  • Historically the most expensive mainstream ambient scribe, which prices out solo clinicians and small independent practices
  • EHR write-back connectors for non-Epic systems are sometimes a separate, additional cost arranged through third-party partners
  • Nurse and radiologist experiences have more limited geographic availability (US-only, with radiology still in preview) than the physician product